Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 4 (HMGN1P4) is a nonfunctional DNA sequence in the human genome that has high sequence similarity to the protein-coding gene for high mobility group nucleosome binding domain 1 (HMGN1). Like other pseudogenes, HMGN1P4 does not produce a functional protein product[3][4]. Most pseudogenes are remnants of gene duplication or retrotransposition events and have accumulated mutations that render them inactive[2][3]. Although a subset of pseudogenes can regulate functional genes at the RNA level, HMGN1P4 itself has no established function, no role as a therapeutic target, and is not a known biomarker or drug target. If you need more information, such as genomic context or potential regulatory roles, please specify, but current knowledge does not indicate functional or therapeutic relevance for HMGN1P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 4 (HMGN1P4).